PALUMBO, Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 96
AS - Asia 46
EU - Europa 46
SA - Sud America 10
AF - Africa 1
OC - Oceania 1
Totale 200
Nazione #
US - Stati Uniti d'America 94
SG - Singapore 22
CN - Cina 14
IT - Italia 13
IE - Irlanda 11
BR - Brasile 7
DE - Germania 7
SE - Svezia 5
VN - Vietnam 4
BE - Belgio 3
CA - Canada 2
HK - Hong Kong 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
EC - Ecuador 1
FI - Finlandia 1
GB - Regno Unito 1
ID - Indonesia 1
IN - India 1
KE - Kenya 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
TR - Turchia 1
Totale 200
Città #
Chandler 14
Santa Clara 13
Dublin 11
Singapore 9
Dearborn 8
Ann Arbor 5
Ashburn 4
Beijing 4
Munich 4
Pisa 4
Brussels 3
Houston 3
Medford 3
Atlanta 2
Buffalo 2
Burlington 2
Cambridge 2
Columbus 2
Dong Ket 2
Duncan 2
Fuzhou 2
Hong Kong 2
Nyköping 2
Princeton 2
Torino 2
Warsaw 2
Amsterdam 1
Aracaju 1
Bangkok 1
Bethesda 1
Boardman 1
Boston 1
Campo Grande 1
Cotia 1
Córdoba 1
Falkenstein 1
Guangzhou 1
Hefei 1
Helsinki 1
Izmir 1
Jakarta 1
Long An 1
Marília 1
Miraflores 1
Nairobi 1
Nanjing 1
New York 1
Norwalk 1
Nuremberg 1
Quito 1
Redondo Beach 1
Salvador 1
San Francisco 1
Shenzhen 1
Silver Spring 1
São Ludgero 1
São Paulo 1
Tianjin 1
Turin 1
Verona 1
Vienna 1
Wilmington 1
Zhengzhou 1
Totale 148
Nome #
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 115
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 88
Totale 203
Categoria #
all - tutte 737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 2 1 0 0 4
2021/202221 1 0 1 1 1 0 1 2 0 0 10 4
2022/202338 2 6 1 4 5 6 5 2 6 1 0 0
2023/202412 2 5 0 0 1 0 0 0 0 1 1 2
2024/202556 0 2 2 5 16 4 2 2 11 3 4 5
2025/202626 11 3 3 5 4 0 0 0 0 0 0 0
Totale 203